BRAF and melanoma: SK-MEL-28 is a lineage of human melanoma that harbors the BRAF V600E mutation [17], which enhances and selects sensitivity to mitogen-activated protein kinase kinase (MEK) inhibition [18] compared to “wild-type” cells, causing deregulation of the proliferation, survival, and metastasis of cancer cells [19].